Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece

Virology Journal

Volumn 8, Issue , 2011, Pages

  Katsoulidou, Antigoni ^a   Rokka, Chrysoula ^a   Issaris, Catherine ^a   Haida, Catherine ^a   Tzannis, Kimon ^a   Sypsa, Vana ^a   Detsika, Maria ^a   Paraskevis, Dimitrios ^a   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; EVALUATION; GENETIC STRAIN; GENETIC VARIABILITY; GREECE; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; NONHUMAN; PERFORMANCE; QUANTITATIVE ANALYSIS; VIRUS LOAD; VIRUS STRAIN; ANALYTICAL EQUIPMENT; CLASSIFICATION; GENETICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR DIAGNOSIS; PLASMA; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

GENETIC VARIATION; GENOTYPE; GREECE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PLASMA; REAGENT KITS, DIAGNOSTIC; VIRAL LOAD;

EID: 78651071856     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-10     Document Type: Article

References (49)

1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. DD Ho AU Neumann AS Perelson W Chen JM Leonard M Markowitz, Nature 1995 373 123 126 10.1038/373123a0 7816094
2. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. JW Mellors A Munoz JV Giorgi JB Margolick CJ Tassoni P Gupta LA Kingsley JA Todd AJ Saah R Detels,, et al. Ann Intern Med 1997 126 946 954 9182471
3. Plasma viral load testing in the management of HIV infection. E Mylonakis M Paliou JD Rich, Am Fam Physician 2001 63 483 490 495-486 11272298
4. HIV update. Diagnostic tests and markers of disease progression and response to therapy. M Zhang J Versalovic, Am J Clin Pathol 2002 118 Suppl 26 32 14569811
5. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. BG Gazzard, HIV Med 2008 9 563 608 10.1111/j.1468-1293.2008.00636.x 18826546
6. Updated antiretroviral treatment guidelines from DHHS and EACS. C del Rio, AIDS Clin Care 2008 20 7 18399008
7. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. ML Collins B Irvine D Tyner E Fine C Zayati C Chang T Horn D Ahle J Detmer LP Shen,, et al. Nucleic Acids Res 1997 25 2979 2984 10.1093/nar/25.15.2979 9224596
8. A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. J Johanson K Abravaya W Caminiti D Erickson R Flanders G Leckie E Marshall C Mullen Y Ohhashi R Perry,, et al. J Virol Methods 2001 95 81 92 10.1016/S0166-0934(01)00297-X 11377715
9. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. T Kievits B van Gemen D van Strijp R Schukkink M Dircks H Adriaanse L Malek R Sooknanan P Lens, J Virol Methods 1991 35 273 286 10.1016/0166-0934(91)90069-C 1726172
10. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Mulder N McKinney C Christopherson J Sninsky L Greenfield S Kwok, J Clin Microbiol 1994 32 292 300 8150937
11. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. D Kern M Collins T Fultz J Detmer S Hamren JJ Peterkin P Sheridan M Urdea R White T Yeghiazarian J Todd, J Clin Microbiol 1996 34 3196 3202 8940471 (Pubitemid 26389381)
12. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. R Sun J Ku H Jayakar JC Kuo D Brambilla S Herman M Rosenstraus J Spadoro, J Clin Microbiol 1998 36 2964 2969 9738051 (Pubitemid 28429422)
13. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. SA Bustin, J Mol Endocrinol 2000 25 169 193 10.1677/jme.0.0250169 11013345
14. Real-time PCR for mRNA quantitation. ML Wong JF Medrano, Biotechniques 2005 39 75 85 10.2144/05391RV01 16060372
15. Genetic diversity of HIV-1: the moving target. M Peeters PM Sharp, Aids 2000 14 Suppl 3 129 140 11086856
16. HIV-1 nomenclature proposal. DL Robertson JP Anderson JA Bradac JK Carr B Foley RK Funkhouser F Gao BH Hahn ML Kalish C Kuiken,, et al. Science 2000 288 55 56 10.1126/science.288.5463.55d 10766634
17. Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. D Paraskevis E Magiorkinis G Magiorkinis V Sypsa V Paparizos M Lazanas P Gargalianos A Antoniadou G Panos G Chrysos,, et al. J Infect Dis 2007 196 1167 1176 10.1086/521677 17955435
18. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. F Damond B Roquebert A Benard G Collin M Miceli P Yeni F Brun-Vezinet D Descamps, J Clin Microbiol 2007 45 3436 3438 10.1128/JCM.00973-07 17715371
19. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. M Gueudin JC Plantier V Lemee MP Schmitt L Chartier T Bourlet A Ruffault F Damond M Vray F Simon, J Acquir Immune Defic Syndr 2007 44 500 505 10.1097/QAI.0b013e31803260df 17259908
20. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. P Swanson C de Mendoza Y Joshi A Golden RL Hodinka V Soriano SG Devare J Hackett Jr, J Clin Microbiol 2005 43 3860 3868 10.1128/JCM.43.8.3860-3868.2005 16081923
21. A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples. N Tang S Huang J Salituro WB Mak G Cloherty J Johanson YH Li G Schneider J Robinson J Hackett,, et al. J Virol Methods 2007 146 236 245 10.1016/j.jviromet.2007.07.003 17707519
22. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. P Swanson V Holzmayer S Huang P Hay A Adebiyi P Rice K Abravaya S Thamm SG Devare J Hackett Jr, J Virol Methods 2006 137 184 192 10.1016/j.jviromet.2006.06.010 16876263
23. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays. LE Scott LD Noble J Moloi L Erasmus WD Venter W Stevens, J Clin Microbiol 2009 47 2209 2217 10.1128/JCM.01761-08 19420172
24. Simultaneous amplification and detection of specific DNA sequences. R Higuchi G Dollinger PS Walsh R Griffith, Biotechnology (NY) 1992 10 413 417 10.1038/nbt0492-413
25. Real time quantitative PCR. CA Heid J Stevens KJ Livak PM Williams, Genome Res 1996 6 986 994 10.1101/gr.6.10.986 8908518
26. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays - LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5. A Katsoulidou M Petrodaskalaki V Sypsa E Papachristou CG Anastassopoulou P Gargalianos A Karafoulidou M Lazanas T Kordossis A Andoniadou A Hatzakis, J Virol Methods 2006 131 168 174 10.1016/j.jviromet.2005.07.014 16194575
27. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. N Desire A Dehee V Schneider C Jacomet C Goujon PM Girard W Rozenbaum JC Nicolas, J Clin Microbiol 2001 39 1303 1310 10.1128/JCM.39.4.1303-1310.2001 11283046
28. Comparison of TaqMan real-time PCR and p24 Elisa for quantification of in vitro HIV-1 replication. SA Klein S Karsten B Ruster C Klebba M Pape OG Ottmann D Hoelzer WK Roth, J Virol Methods 2003 107 169 175 10.1016/S0166-0934(02) 00230-6 12505631
29. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. S Palmer AP Wiegand F Maldarelli H Bazmi JM Mican M Polis RL Dewar A Planta S Liu JA Metcalf,, et al. J Clin Microbiol 2003 41 4531 4536 10.1128/JCM.41.10.4531-4536. 2003 14532178
30. TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. C Drosten E Seifried WK Roth, J Clin Microbiol 2001 39 4302 4308 10.1128/JCM.39.12.4302-4308.2001 11724836
31. Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. A Katsoulidou E Papachristou M Petrodaskalaki V Sypsa CG Anastassopoulou P Gargalianos A Karafoulidou M Lazanas T Kordossis A Andoniadou A Hatzakis, J Virol Methods 2004 121 93 99 10.1016/j.jviromet.2004.06.007 15350738
32. PAUP*: phylogenetic analysis using parsimony (*and other methods), version 4.0 beta for Macintosh. D Swofford, Sinauer, Sunderland and Massachusetts, USA 2002
33. Statistical methods in medical research. P Armitage G Berry JNS Matthews, Blackwell Science, Oxford, Malden, MA 2002
34. Statistical methods for assessing agreement between two methods of clinical measurement. JM Bland DG Altman, Lancet 1986 1 307 310 2868172
35. Measuring agreement in method comparison studies. JM Bland DG Altman, Stat Methods Med Res 1999 8 135 160 10.1191/096228099673819272 10501650
36. Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa. JA Crump LE Scott E Msuya AB Morrissey EE Kimaro JF Shao WS Stevens, J Virol Methods 2009 162 218 222 10.1016/j.jviromet. 2009.08.013 19729037
37. Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma. V Foulongne B Montes MN Didelot-Rousseau M Segondy, J Clin Microbiol 2006 44 2963 2966 10.1128/JCM.00341-06 16891517
38. Comparison of the Abbott RealTime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs. CR Sloma JJ Germer TM Gerads JN Mandrekar PS Mitchell JD Yao, J Clin Microbiol 2009 47 889 895 10.1128/JCM.02231-08 19193837
39. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA. D Wolff A Gerritzen, Clin Chem Lab Med 2007 45 917 922 10.1515/CCLM.2007.149 17617038
40. Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. CC Ginocchio XP Wang MH Kaplan G Mulligan D Witt JW Romano M Cronin R Carroll, J Clin Microbiol 1997 35 2886 2893 9350753
41. Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay. K Sebire K McGavin S Land T Middleton C Birch, J Clin Microbiol 1998 36 493 498 9466765
42. Comparison of the Abbott RealTime HIV-1 and HCV viral load assays with commercial competitor assays. M Schutten, Expert Rev Mol Diagn 2008 8 369 377 10.1586/14737159.8.4.369 18598219
43. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. P Swanson S Huang V Holzmayer P Bodelle J Yamaguchi C Brennan R Badaro C Brites K Abravaya SG Devare J Hackett Jr, J Virol Methods 2006 134 237 243 10.1016/j.jviromet.2006.01.012 16510195
44. Impaired quantification of plasma HIV-1 RNA with a commercialized real-time PCR assay in a couple of HIV-1-infected individuals. P Colson C Solas J Moreau A Motte M Henry C Tamalet, J Clin Virol 2007 39 226 229 10.1016/j.jcv.2007.04.007 17532257
45. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. S Wain-Hobson, Curr Top Microbiol Immunol 1992 176 181 193 1600752
46. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. P Swanson S Huang K Abravaya C de Mendoza V Soriano SG Devare J Hackett Jr, J Virol Methods 2007 141 49 57 10.1016/j.jviromet.2006.11.026 17184853
47. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. P Braun R Ehret F Wiesmann F Zabbai M Knickmann R Kuhn S Thamm G Warnat H Knechten, Clin Chem Lab Med 2007 45 93 99 10.1515/CCLM.2007.008 17243923
48. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. M Schutten D Peters NK Back M Beld K Beuselinck V Foulongne AM Geretti L Pandiani C Tiemann HG Niesters, J Clin Microbiol 2007 45 1712 1717 10.1128/JCM.02385-06 17409216
49. Impact of discrepancies between the Abbott RrealTime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. M Wirden R Tubiana F Marguet I Leroy A Simon M Bonmarchand Z Ait-Arkoub R Murphy AG Marcelin C Katlama V Calvez, J Clin Microbiol 2009 47 1543 1545 10.1128/JCM.02134-08 19297599